These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 20670294)

  • 21. Brucella requires a functional Type IV secretion system to elicit innate immune responses in mice.
    Roux CM; Rolán HG; Santos RL; Beremand PD; Thomas TL; Adams LG; Tsolis RM
    Cell Microbiol; 2007 Jul; 9(7):1851-69. PubMed ID: 17441987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions.
    Salcedo SP; Marchesini MI; Degos C; Terwagne M; Von Bargen K; Lepidi H; Herrmann CK; Santos Lacerda TL; Imbert PR; Pierre P; Alexopoulou L; Letesson JJ; Comerci DJ; Gorvel JP
    Front Cell Infect Microbiol; 2013; 3():28. PubMed ID: 23847770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brucella adaptation and survival at the crossroad of metabolism and virulence.
    Barbier T; Nicolas C; Letesson JJ
    FEBS Lett; 2011 Oct; 585(19):2929-34. PubMed ID: 21864534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between professional phagocytes and Brucella spp.
    Liautard JP; Gross A; Dornand J; Köhler S
    Microbiologia; 1996 Jun; 12(2):197-206. PubMed ID: 8767704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum.
    Celli J; de Chastellier C; Franchini DM; Pizarro-Cerda J; Moreno E; Gorvel JP
    J Exp Med; 2003 Aug; 198(4):545-56. PubMed ID: 12925673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bartonella and Brucella--weapons and strategies for stealth attack.
    Ben-Tekaya H; Gorvel JP; Dehio C
    Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23906880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of virulence in Brucella: an eclectic repertoire of transcription factors defines the complex architecture of the virB promoter.
    Sieira R
    Future Microbiol; 2013 Sep; 8(9):1193-208. PubMed ID: 24020745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection.
    Spera JM; Ugalde JE; Mucci J; Comerci DJ; Ugalde RA
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16514-9. PubMed ID: 17053080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic cells and Brucella spp. interaction: the sentinel host and the stealthy pathogen.
    Avila-Calderón ED; Flores-Romo L; Sharon W; Donis-Maturano L; Becerril-García MA; Arreola MGA; Reynoso BA; Güemes FS; Contreras-Rodríguez A
    Folia Microbiol (Praha); 2020 Feb; 65(1):1-16. PubMed ID: 30783994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brucella T4SS: the VIP pass inside host cells.
    Lacerda TL; Salcedo SP; Gorvel JP
    Curr Opin Microbiol; 2013 Feb; 16(1):45-51. PubMed ID: 23318140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular battle between host and bacterium: recognition in innate immunity.
    Bardoel BW; Strijp JA
    J Mol Recognit; 2011; 24(6):1077-86. PubMed ID: 22038814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic beta-1,2-glucan is a Brucella virulence factor required for intracellular survival.
    Arellano-Reynoso B; Lapaque N; Salcedo S; Briones G; Ciocchini AE; Ugalde R; Moreno E; Moriyón I; Gorvel JP
    Nat Immunol; 2005 Jun; 6(6):618-25. PubMed ID: 15880113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brucella: a pathogen without classic virulence genes.
    Seleem MN; Boyle SM; Sriranganathan N
    Vet Microbiol; 2008 May; 129(1-2):1-14. PubMed ID: 18226477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-mediated immune responses differentiate infections with Brucella suis from Yersinia enterocolitica serotype O:9 in pigs.
    Riber U; Jungersen G
    Vet Immunol Immunopathol; 2007 Mar; 116(1-2):13-25. PubMed ID: 17270281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of the human pathogenic Brucella species with their hosts.
    Atluri VL; Xavier MN; de Jong MF; den Hartigh AB; Tsolis RM
    Annu Rev Microbiol; 2011; 65():523-41. PubMed ID: 21939378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological properties and dog response to a variant (M-) strain of Brucella canis.
    Carmichael LE; Zoha SJ; Flores-Castro R
    Dev Biol Stand; 1984; 56():649-56. PubMed ID: 6489639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-Like Receptors 2 and 4 Cooperate in the Control of the Emerging Pathogen
    Arias MA; Santiago L; Costas-Ramon S; Jaime-Sánchez P; Freudenberg M; Jiménez De Bagüés MP; Pardo J
    Front Cell Infect Microbiol; 2016; 6():205. PubMed ID: 28119856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host response to Brucella infection: review and future perspective.
    Elfaki MG; Alaidan AA; Al-Hokail AA
    J Infect Dev Ctries; 2015 Jul; 9(7):697-701. PubMed ID: 26230118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The virB operon is essential for lethality of Brucella microti in the Balb/c murine model of infection.
    Hanna N; Jiménez de Bagüés MP; Ouahrani-Bettache S; El Yakhlifi Z; Köhler S; Occhialini A
    J Infect Dis; 2011 Apr; 203(8):1129-35. PubMed ID: 21451001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virulence factors that modulate the cell biology of Listeria infection and the host response.
    Mostowy S; Cossart P
    Adv Immunol; 2012; 113():19-32. PubMed ID: 22244577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.